HU185857B - Process for preparing imidazol/1,2-a/pyridines - Google Patents

Process for preparing imidazol/1,2-a/pyridines Download PDF

Info

Publication number
HU185857B
HU185857B HU81137A HU13781A HU185857B HU 185857 B HU185857 B HU 185857B HU 81137 A HU81137 A HU 81137A HU 13781 A HU13781 A HU 13781A HU 185857 B HU185857 B HU 185857B
Authority
HU
Hungary
Prior art keywords
pyridine
hydrogen
formula
benzyloxy
alkyl
Prior art date
Application number
HU81137A
Other languages
English (en)
Hungarian (hu)
Inventor
James A Bristol
Chester Pushalski
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of HU185857B publication Critical patent/HU185857B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU81137A 1980-01-23 1981-01-22 Process for preparing imidazol/1,2-a/pyridines HU185857B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11447380A 1980-01-23 1980-01-23

Publications (1)

Publication Number Publication Date
HU185857B true HU185857B (en) 1985-04-28

Family

ID=22355431

Family Applications (1)

Application Number Title Priority Date Filing Date
HU81137A HU185857B (en) 1980-01-23 1981-01-22 Process for preparing imidazol/1,2-a/pyridines

Country Status (21)

Country Link
EP (1) EP0033094B1 (Direct)
JP (1) JPS56113782A (Direct)
KR (1) KR850000240B1 (Direct)
AU (1) AU540840B2 (Direct)
CA (1) CA1167845A (Direct)
DE (1) DE3166531D1 (Direct)
DK (1) DK25081A (Direct)
FI (1) FI810147L (Direct)
GR (1) GR72960B (Direct)
HK (1) HK94187A (Direct)
HU (1) HU185857B (Direct)
IE (1) IE50682B1 (Direct)
IL (1) IL61939A (Direct)
MA (1) MA19048A1 (Direct)
MY (1) MY8700760A (Direct)
NO (1) NO157781C (Direct)
NZ (1) NZ196071A (Direct)
OA (1) OA06727A (Direct)
PT (1) PT72370B (Direct)
SG (1) SG70887G (Direct)
ZA (1) ZA81219B (Direct)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460584A (en) * 1981-03-13 1984-07-17 Imperial Chemical Industries Plc Nitrogen heterocycles
US4463005A (en) * 1981-03-18 1984-07-31 Imperial Chemical Industries Plc Bicyclic guanidines
EP0068378B1 (en) * 1981-06-26 1986-03-05 Schering Corporation Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
JPS61218589A (ja) * 1985-03-26 1986-09-29 Eisai Co Ltd ５―（６―イミダゾ〔１，２―ａ〕ピリジニル）ピリジン誘導体
GB8530878D0 (en) * 1985-12-16 1986-01-29 Fujisawa Pharmaceutical Co Imidazopyridine compounds
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
GB8514080D0 (en) * 1985-06-04 1985-07-10 Fujisawa Pharmaceutical Co Imidazopyridine compounds
EP0228006A1 (en) * 1985-12-16 1987-07-08 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine compounds and processes for preparation thereof
FR2593818B1 (fr) * 1986-02-05 1988-04-29 Synthelabo Derives d'acylaminomethyl-3 imidazo(1,2-a)pyridine, leur preparation et leur application en therapeutique
ATE62687T1 (de) * 1986-01-22 1991-05-15 Synthelabo Acylaminomethylimidazo(1,2-a>pyrimidinderivate, ihre herstellung und therapeutische verwendung.
US4831041A (en) * 1986-11-26 1989-05-16 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine compounds and processes for preparation thereof
IL86269A0 (en) * 1987-05-08 1988-11-15 Byk Gulden Lomberg Chem Fab Imidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
ATE145907T1 (de) * 1987-07-16 1996-12-15 Byk Gulden Lomberg Chem Fab Imidazo(1,2-a>pyridine
GB8722488D0 (en) * 1987-09-24 1987-10-28 Fujisawa Pharmaceutical Co Imidazopyridine compound
AT390438B (de) * 1987-10-08 1990-05-10 Yamanouchi Pharma Co Ltd Neue imidazo(1,2-a)pyridinderivate und deren herstellung und diese enthaltende pharmazeutische zubereitungen
EP0368158A1 (de) * 1988-11-07 1990-05-16 Byk Gulden Lomberg Chemische Fabrik GmbH Neue Imidazopyridine
KR910011852A (ko) * 1989-12-04 1991-08-07 폴 디. 매튜카이티스 신경독 장해 치료용 이미다조[1,2-a]피리디닐알킬 화합물
US5716964A (en) * 1989-12-04 1998-02-10 G.D. Searle & Co. Tetrazolyl substituted imidazo 1,2-a!pyridinylalkyl compounds for treatment of neurotoxic injury
IE904346A1 (en) * 1989-12-04 1991-06-05 Searle & Co IMIDAZO[1,2-a]PYRIDINYLALKYL COMPOUNDS FOR TREATMENT OF¹NEUROTOXIC INJURY
DE4010797A1 (de) * 1990-04-04 1991-10-10 Hoechst Ag Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung
US5464843A (en) * 1992-06-23 1995-11-07 G.D. Searle & Co. Imidazo[1,2-a]pyridinyldiacid compounds for cognitive enhancement and for treatment of cognitive disorders and neutrotoxic injury
US5574042A (en) * 1992-11-02 1996-11-12 Fujisawa Pharmaceutical Co., Ltd Imidazo [1,2-a] pyridines and their pharmaceutical use
IL108520A (en) * 1993-02-15 1997-09-30 Byk Gulden Lomberg Chem Fab 2, 3, 8-TRISUBSTITUTED IMIDAZO £1, 2-a| PYRIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US5824687A (en) * 1993-04-22 1998-10-20 Byk Gulden Lomberg Chemische Fabrik Gmbh Pyridinium salts and their use for the control of helicobacter bacteria
UA48122C2 (uk) * 1993-10-11 2002-08-15 Бік Гульден Ломберг Хеміше Фабрік Гмбх АЛКОКСІАЛКІЛКАРБАМАТИ ІМІДАЗО[1,2-а]ПІРИДИНІВ, СПОСІБ ЇХ ОДЕРЖАННЯ ТА ЛІКАРСЬКИЙ ЗАСІБ НА ЇХ ОСНОВІ
MX9700624A (es) * 1994-07-28 1997-12-31 Byk Gulden Lomberg Chem Fab Azolidinonas de imidazopiridina.
WO1996005199A1 (de) * 1994-08-12 1996-02-22 Byk Gulden Lomberg Chemische Fabrik Gmbh Imidazopyridinsalz
WO1996033195A1 (en) * 1995-04-21 1996-10-24 Shinnippon Pharmaceutical Inc. FUSED IMIDAZO[1,2-a]PYRIDINES
ATE294802T1 (de) * 1996-01-26 2005-05-15 Altana Pharma Ag 3-alkylimidazopyridine
WO1997027193A1 (de) * 1996-01-26 1997-07-31 Byk Gulden Lomberg Chemische Fabrik Gmbh Halogenimidazopyridine
DE19602855A1 (de) * 1996-01-26 1997-07-31 Byk Gulden Lomberg Chem Fab Neue 3-Methylimidazopyridine
SE9700661D0 (sv) * 1997-02-25 1997-02-25 Astra Ab New compounds
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
SE9802793D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
DE10001037C1 (de) 2000-01-13 2001-12-13 Byk Gulden Lomberg Chem Fab Verfahren und Zwischenprodukte zur Herstellung von Imidazopyridinen
CA2311483A1 (en) 2000-06-12 2001-12-12 Gregory N Beatch IMIDAZO [1,2-A] PYRIDINIC ETHERS AND USES THEREOF
SE0003186D0 (sv) * 2000-09-07 2000-09-07 Astrazeneca Ab New process
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
EP1370261A2 (en) * 2001-03-08 2003-12-17 AstraZeneca AB New use
SE0102808D0 (sv) * 2001-08-22 2001-08-22 Astrazeneca Ab New compounds
DE10145457A1 (de) 2001-09-14 2003-04-03 Basf Ag Substituierte Imidazo[1,2-a]-5,6,7,8-tetrahydropyridin-8-one, Verfahren zu ihrer Herstellung, sowie deren Verwendung zur Herstellung von Imidazo[1,2,-a]pyridinen
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
EP1534278A4 (en) 2002-08-01 2006-09-06 Nitromed Inc NITROSED PROTONATE PUMP INHIBITORS, COMPOSITIONS AND USE METHOD
SE0301904D0 (sv) 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound II with therapeutic effect
WO2005026164A1 (en) * 2003-09-18 2005-03-24 Altana Pharma Ag Pharmacologically active imidazo[4,5-c]pyridines
EP1682133A1 (en) 2003-11-03 2006-07-26 AstraZeneca AB Imidazo 1,2-a pyridine derivatives for the treatment of silent gastro-esophageal reflux
FI20086158A0 (fi) 2008-12-03 2008-12-03 Mikael Dahlstroem Imidatsopyridiinijohdannaiset
US8883819B2 (en) 2011-09-01 2014-11-11 Irm Llc Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension
US9073921B2 (en) 2013-03-01 2015-07-07 Novartis Ag Salt forms of bicyclic heterocyclic derivatives
KR101777971B1 (ko) * 2016-07-05 2017-09-12 제일약품주식회사 이미다조[1,2-a]피리딘 유도체, 이의 제조방법 및 이의 용도

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4096264A (en) * 1975-12-09 1978-06-20 Merck & Co., Inc. Certain substituted imidazo [1,2-a] pyridines
US4105767A (en) * 1977-03-28 1978-08-08 Merck & Co., Inc. Imidazo [1,2-a] pyridines substituted with a thienyl, thiazolyl, or thiadiazolyl group

Also Published As

Publication number Publication date
SG70887G (en) 1988-03-04
NO157781C (no) 1988-05-25
DE3166531D1 (en) 1984-11-15
MY8700760A (en) 1987-12-31
IL61939A0 (en) 1981-02-27
KR850000240B1 (ko) 1985-03-12
AU540840B2 (en) 1984-12-06
FI810147A7 (fi) 1981-07-24
MA19048A1 (fr) 1981-10-01
DK25081A (da) 1981-07-24
ZA81219B (en) 1982-01-27
AU6633781A (en) 1981-07-30
GR72960B (Direct) 1984-01-19
OA06727A (fr) 1982-06-30
HK94187A (en) 1987-12-18
IE810108L (en) 1981-07-23
PT72370B (en) 1982-07-23
PT72370A (en) 1981-02-01
KR830005212A (ko) 1983-08-03
JPS56113782A (en) 1981-09-07
NO810198L (no) 1981-07-24
EP0033094A1 (en) 1981-08-05
NZ196071A (en) 1984-05-31
IL61939A (en) 1986-01-31
IE50682B1 (en) 1986-06-11
NO157781B (no) 1988-02-08
FI810147L (fi) 1981-07-24
EP0033094B1 (en) 1984-10-10
CA1167845A (en) 1984-05-22

Similar Documents

Publication Publication Date Title
HU185857B (en) Process for preparing imidazol/1,2-a/pyridines
EP0535529B1 (en) Indole derivatives and anti-ulcer compositions
US4725601A (en) Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
JP2648793B2 (ja) ８ａ，９−ジヒドロ−１Ｈ−ジイミダゾ〔１，５−ａ：４′，５′−ｄ〕ピリジン誘導体
RU2136682C1 (ru) Имидазопиридины, способ их получения, фармацевтическая композиция на их основе и способ получения фармацевтической композиции
US4616025A (en) Thiazolidine derivatives, process for the preparation and pharmaceutical compositions thereof
NO159724B (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazo(1,2-a)-pyraziner.
HK61485A (en) 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridine-3-carboxylic acids, process for their preparation and pharmaceutical compositions containing them
SK61594A3 (en) Proteolitic enzyme inhibitors on saccharine derivatives basis
KR100717489B1 (ko) 피리도피리미디논 화합물, 이의 제조 방법 및 이를함유하는 약제 조성물
US5223503A (en) 6-substituted pyrido[2,3-d]pyrimidines as antineoplastic agents
EP0640606A1 (en) Thienopyrimidine derivatives, their production and use
WO1993016076A1 (en) 3-(1h^_-tetrazol-5-yl)-4h^_-pyrido[1,2-a^_]pyrimidine-4-ones, pharmaceutical compositions containing the same and the preparation thereof
HU197749B (en) Process for producing /3,4-d/pyrimidine derivatives and pharmaceutical compositions comprising these compounds as active ingredient
US4940711A (en) Antihypertensive N-piperazinylalkanoylanilides
US4409226A (en) Imidazo[1,5-a]pyridines
JPH06199866A (ja) ジアゼピン誘導体
JPH05117273A (ja) 医薬化合物
EP0154494A2 (en) Phenylimidazole inotropic agents
EP0329126B1 (en) Heterocyclic compounds and antiulcer agents
HU181608B (en) Process for producing imidazo-thieno-pyrimidine derivatives
EP0121341B1 (en) Triazolo(4,3-c)pyrimidines and triazolo(1,5-c)pyrimidines substituted by nitrogen-containing heterocyclic rings
US3887570A (en) Derivatives of pyrazolo(3,4-b)thieno(2,3-d)pyridine-2-carboxylic acids
FI77032C (fi) Foerfarande foer framstaellning av 6-fenyl-11h-pyrido/2,3-b//1,4/bensodiazepiner.
SU1301315A3 (ru) Способ получени производных @ -пиразоло /1,5- @ /пиримидина или их солей (его варианты)